Genelux (GNLX) Liabilities and Shareholders Equity (2022 - 2026)

Genelux's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $32.4 million for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity changed N/A year-over-year to $32.4 million in Q1 2026; TTM through Mar 2026 was $108.6 million, a 9.6% decrease from a year earlier, with the FY2025 full-year figure at $19.0 million, down 45.19% from the prior year.
• Liabilities and Shareholders Equity grew to $32.4 million in Q1 2026 per GNLX's latest filing, from $19.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $45.2 million in Q2 2024 and bottomed at $5.5 million in Q4 2022.
• The 5-year median for Liabilities and Shareholders Equity is $32.2 million (2025), against an average of $29.2 million.
• Across the five-year window, Liabilities and Shareholders Equity surged 404.3% in 2023 and tumbled 45.19% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $5.5 million in 2022, then jumped by 404.3% to $27.9 million in 2023, then increased by 24.46% to $34.7 million in 2024, then sank by 45.19% to $19.0 million in 2025, then surged by 70.14% to $32.4 million in 2026.
• Per Business Quant, the three latest GNLX Liabilities and Shareholders Equity figures stand at $32.4 million (Q1 2026), $19.0 million (Q4 2025), and $25.0 million (Q3 2025).